Evogene Ltd. plans to list on the Nasdaq Global Market.
The company will delist from the New York Stock Exchange and start trading on Nasdaq on Dec. 30. under the EVGN symbol.
Evogene to list on Nasdaq Global Market
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective